Dr. Michael Elman, MD
Claim this profileElman Retina Group, P.A.
Studies Macular Edema
Studies Diabetic Macular Edema
8 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Michael Elman, MD is currently running
Immediate vs. Deferred Surgery
for Macular Pucker
This trial studies the best time for eye surgery to remove a membrane that can cause vision problems. It focuses on patients with noticeable eye changes but still good vision. The goal is to see if surgery leads to better vision outcomes and to understand how symptoms like visual distortion affect patients.
Recruiting1 award N/A
Fenofibrate
for Diabetic Retinopathy
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the drug safely. If this study demonstrates that fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community of retina specialists, a new strategy to prevent vision threatening complications of diabetes could be widely adopted. Widespread use of an oral agent effective at reducing worsening of DR would decrease the numbers of patients who undergo more invasive and much more expensive treatment for DR and who are consequently at risk for side effects that adversely affect visual function. This study will also assess the relationship of glycemic variability, as measured by continuous glucose monitoring with DR outcomes. Ancillary studies will characterize functional and structural outcomes in this cohort.
Recruiting1 award Phase 35 criteria
More about Michael Elman, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Michael Elman, MD has experience with
- Placebo
- Fenofibrate
- Immediate Vitrectomy
- Deferred Vitrectomy
- Tonabersat
- Ranibizumab
Breakdown of trials Michael Elman, MD has run
Macular Edema
Diabetic Macular Edema
Age-Related Macular Degeneration
Swelling
Retinal Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Elman, MD specialize in?
Michael Elman, MD focuses on Macular Edema and Diabetic Macular Edema. In particular, much of their work with Macular Edema has involved treating patients, or patients who are undergoing treatment.
Is Michael Elman, MD currently recruiting for clinical trials?
Yes, Michael Elman, MD is currently recruiting for 3 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Michael Elman, MD has studied deeply?
Yes, Michael Elman, MD has studied treatments such as Placebo, Fenofibrate, Immediate Vitrectomy.
What is the best way to schedule an appointment with Michael Elman, MD?
Apply for one of the trials that Michael Elman, MD is conducting.
What is the office address of Michael Elman, MD?
The office of Michael Elman, MD is located at: Elman Retina Group, P.A., Baltimore, Maryland 21237 United States. This is the address for their practice at the Elman Retina Group, P.A..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.